Sonoma Pharmaceuticals (SNOA) EPS (Basic) Growth (1y) (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 88.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 88.65% |
| Mar 31, 2026 | 44.82% |
| Dec 31, 2025 | 24.57% |
| Sep 30, 2025 | 45.01% |
| Jun 30, 2025 | 43.67% |
| Mar 31, 2025 | 73.36% |
| Dec 31, 2024 | 60.08% |
| Sep 30, 2024 | 99.99% |
| Jun 30, 2024 | 99.98% |
| Mar 31, 2024 | 99.97% |
| Dec 31, 2023 | 99.99% |
| Sep 30, 2023 | 12.34% |
| Jun 30, 2023 | -100,252.32% |
| Sep 30, 2022 | -768,883.23% |
| Jun 30, 2022 | 45.48% |
| Sep 30, 2021 | -176.34% |
| Jun 30, 2021 | -201.66% |
| Mar 31, 2021 | -1,397.81% |
| Dec 31, 2020 | -113.92% |
| Sep 30, 2020 | -123.92% |